Valuation : Maravai LifeSciences Holdings, Inc.

Market Cap 1.1B 949M 894M 816M 1.52B 104B 1.53B 10.59B 4.11B 53.12B 4.13B 4.04B 175B P/E 2026 *
-24x
P/E 2027 * -31.1x
Enterprise Value 1.15B 991M 934M 852M 1.59B 109B 1.6B 11.06B 4.29B 55.48B 4.31B 4.22B 182B EV / Sales 2026 *
5.43x
EV / Sales 2027 * 4.87x
Free-Float
45.44%
Yield 2026 *
-
Yield 2027 * -
1 day+1.10%
1 week-18.00%
Current month-3.40%
1 month+12.33%
3 months+55.37%
6 months+107.30%
Current year+127.08%
1 week 7.27
Extreme 7.27
8.98
1 month 5.41
Extreme 5.41
9.42
Current year 2.8
Extreme 2.8
9.42
1 year 2.3
Extreme 2.3
9.42
3 years 1.66
Extreme 1.665
11.56
5 years 1.66
Extreme 1.665
61.02
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/10/26 Tax

Chief Executive Officer

-29,250 0.0198%
7/30/26 Tax

Chief Financial Officer

-5,465 0.0037%
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
Change 5-day change 1-year change 3-year change Capi.($)
+1.10%-18.00%+204.96%-28.35% 1.09B
+1.31%-6.06%+87.10%+262.11% 3.88B
+4.11%+2.13%+286.55%+40.16% 3.75B
+3.34%+1.91%+47.92%+68.09% 3.49B
+1.29%-2.36%+263.10%+409.76% 2.53B
-2.35%-7.08%-29.90%-29.70% 2.21B
+3.11%+9.01%+44.15% - 1.64B
-2.73%+2.07%+25.64%+45.25% 1.1B
-3.61%-9.62%+20.37%+62.07% 642M
-1.26%-4.38%-35.72%-4.75% 537M
Average +0.05%-4.58%+91.42%+91.63% 2.09B
Weighted average by Cap. +0.78%-3.87%+119.69%+126.60%

Financials

2026 *2027 *
Net sales 212M 183M 172M 157M 293M 20.09B 295M 2.04B 790M 10.22B 794M 777M 33.61B 226M 195M 184M 167M 312M 21.44B 315M 2.17B 843M 10.9B 848M 829M 35.86B
Net income -48.85M -42.17M -39.72M -36.24M -67.62M -4.64B -68.18M -470M -182M -2.36B -183M -179M -7.76B -33.6M -29M -27.32M -24.92M -46.5M -3.19B -46.89M -323M -125M -1.62B -126M -123M -5.34B
Net Debt 48.8M 42.12M 39.68M 36.2M 67.54M 4.63B 68.11M 470M 182M 2.36B 183M 179M 7.75B -385K -333K -313K -286K -533K -36.58M -538K -3.71M -1.44M -18.61M -1.45M -1.41M -61.19M
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
415
Date Price Change Volume
26-09-02 US$7.380 +1.10% 3,668,054
26-09-01 US$7.300 -4.45% 2,698,378
26-08-31 US$7.640 -0.52% 5,318,132
26-08-28 US$7.680 -8.24% 5,564,528
26-08-27 US$8.370 -5.96% 3,174,523
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7.380USD
Average target price
7.300USD
Spread / Average Target
-1.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock